The U.K.’s drug regulator will address safety concerns surrounding AstraZeneca Plc’s Covid-19 vaccine on Wednesday, as fears grow that the government’s inoculation targets will be put at risk.
Representatives from the U.K.’s Medicines and Healthcare products Regulatory Agency and the government’s vaccine committee will speak at 3 p.m., at the same time as the European Medicines Agency holds its own press briefing.
